The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based Insilico Medicine. Dr. William Soliman joins ABC News Live to explain. Subscribe to ABC News on YouTube: https://abcnews.visitlink.me/59aJ1G ABC News is your daily source of breaking national and world news, exclusive interviews and 24/7 live streaming coverage. https://abcnews.com Download the ABC News app for the latest headlines and alerts: https://abcnews.com/devices